Marksans Pharma to acquire 100% stake in Dubai-based Access Healthcare for Medical Products LLC

Marksans Pharma to acquire 100% stake in Dubai-based Access Healthcare for Medical Products LLC

By, Admin 26 April 2022

Marksans Pharma Limited today signed a share purchase agreement to acquire a 100% stake in Access Healthcare for Medical Products L.L.C, a Dubai-based frontmarketing and promotion company Marksans Pharma Limited today signed a share purchase agreement to acquire a 100% stake in Access Healthcare for Medical Products L.L.C, a Dubaibased front- marketing and promotion company.This transaction was approved by the Board of Directors of Marksans Pharma on April 23, 2022. Access Healthcare for Medical Products (Access Healthcare)provides pharmaceutical companies innovative marketing and sales solutions in the MENA (Middle East & North Africa) region The Company supplies these products in the UAE and other neighboring countries. In the UAE market, the company supplies products through the Dubai Health Authority (DHA). It has market authorizations by the UAE regulatory authorities for various products. For the year ended December 2021, Access Healthcare for Medical Products posted revenues of AED 12 Mn (INR 250 Mn) and a profit after tax of AED 4.5 Mn (INR 94 Mn). Commenting on the transaction, Mark Saldanha, Promoter & Managing Director of Marksans Pharma said

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!